Table 1 Summary of clinicopathologic characteristics of the patients
Tumours (from survivors/deceased patients) | |
|---|---|
Total Tumours | 98 (48/50) |
Tumours used in QPCR analysis | 30 (15/15) |
Mean age (years) | 60 (57/62) (range 28-81) |
FIGO Staging | |
IIIa | 10 (7/3) |
IIIb | 14 (7/7) |
IIIc | 73 (33/40) |
IV | 1 (1/0) |
Surgery | |
Radically operated | 20 (13/7) |
Residual tumour | 75 (34/41) |
Not available | 3 (1/2) |
Differentiation | |
Well | 15 (10/5) |
Moderate | 22 (10/12) |
Poor | 59 (26/33) |
Not available | 2 (2/0) |
Treatment | |
farmorubicine, carboplatin and cyclophosphamide | 31 (16/15) |
paclitaxel and carboplatin | 67 (32/35) |